ACER2 and diffuse large B-cell lymphoma: Enhanced ACER2 expression hydrolyzed ceramides, disrupting the balance between Cer and S1P, activating the ERK and PI3K/AKT pathways, and leading to diffuse large B-cell lymphoma (DLBCL) tumorigenesis (43).